- KR-31831, a new synthetic anti-ischemic agent, inhibits in vivo and in vitro angiogenesis
-
Yi EY, Park SY, Song HS, Son MJ, Yi KY, Yoo SE, Kim YJ
- KMID: 1098084
- Exp Mol Med.
- 2006 Oct;38(5):502-508.
Angiogenesis is considered to be an integral process to the growth and spread of solid tumors. Anti-angiogenesis therapy recently has been found to be one of the most promising anti-cancer... -
- CITED
-
- Close
- SHARE
-
- Close
